[HTML][HTML] GM-CSF: A double-edged sword in cancer immunotherapy

A Kumar, A Taghi Khani, A Sanchez Ortiz… - Frontiers in …, 2022 - frontiersin.org
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that drives the
generation of myeloid cell subsets including neutrophils, monocytes, macrophages, and …

Electroporation delivery of DNA vaccines: prospects for success

NY Sardesai, DB Weiner - Current opinion in immunology, 2011 - Elsevier
A number of noteworthy technology advances in DNA vaccines research and development
over the past few years have led to the resurgence of this field as a viable vaccine modality …

DNA vaccines: immunology, application, and optimization

S Gurunathan, DM Klinman… - Annual review of …, 2000 - annualreviews.org
The development and widespread use of vaccines against infectious agents have been a
great triumph of medical science. One reason for the success of currently available vaccines …

[HTML][HTML] Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know

Y Shi, CH Liu, AI Roberts, J Das, G Xu, G Ren, Y Zhang… - Cell research, 2006 - nature.com
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an important hematopoietic
growth factor and immune modulator. GM-CSF also has profound effects on the functional …

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

RR MacGregor, JD Boyer, KE Ugen… - Journal of infectious …, 1998 - academic.oup.com
A DNA-based vaccine containing human immunodeficiency virus type 1 (HIV-1) env and rev
genes was tested for safety and host immune response in 15 asymptomatic HIV-infected …

Interleukin-12: a cytokine at the interface of inflammation and immunity

G Trinchieri - Advances in immunology, 1998 - Elsevier
Publisher Summary Although interleukin-12 (IL-12) has been discovered only relatively
recently, a remarkable level of knowledge has been obtained for this cytokine, and many …

Immunotherapy targeting HPV16/18 generates potent immune responses in HPV-associated head and neck cancer

C Aggarwal, RB Cohen, MP Morrow, KA Kraynyak… - Clinical Cancer …, 2019 - AACR
Purpose: Clinical responses with programmed death (PD-1) receptor–directed antibodies
occur in about 20% of patients with advanced head and neck squamous cell cancer …

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

S André, B Seed, J Eberle, W Schraut… - Journal of …, 1998 - Am Soc Microbiol
ABSTRACT DNA vaccination elicits humoral and cellular immune responses and has been
shown to confer protection against several viral, bacterial, and parasitic pathogens. Here we …

[HTML][HTML] Oral somatic transgene vaccination using attenuated S. typhimurium

A Darji, CA Guzmán, B Gerstel, P Wachholz… - Cell, 1997 - cell.com
An attenuated strain of S. typhimurium has been used as a vehicle for oral genetic
immunization. Eukaryotic expression vectors containing truncated genes of ActA and …

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

SA Bryan, BJ O'Connor, S Matti, MJ Leckie, V Kanabar… - The Lancet, 2000 - thelancet.com
Summary Background Interleukin-12 (IL-12) is a macrophage-derived cytokine that
modulates T lymphocyte responses and has the capacity to suppress allergic and …